Curi RMB Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-195,890
| Closed | -$286K | – | 660 |
|
|
2025
Q1 | $286K | Buy |
195,890
+46,313
| +31% | +$67.6K | 0.01% | 439 |
|
|
2024
Q4 | $319K | Hold |
149,577
| – | – | 0.01% | 454 |
|
|
2024
Q3 | $419K | Buy |
149,577
+48,202
| +48% | +$135K | 0.01% | 450 |
|
|
2024
Q2 | $236K | Hold |
101,375
| – | – | 0.01% | 501 |
|
|
2024
Q1 | $453K | Buy |
101,375
+27,560
| +37% | +$123K | 0.01% | 447 |
|
|
2023
Q4 | $237K | Hold |
73,815
| – | – | 0.01% | 475 |
|
|
2023
Q3 | $234K | Buy |
73,815
+34,980
| +90% | +$111K | 0.01% | 460 |
|
|
2023
Q2 | $193K | Hold |
38,835
| – | – | 0.01% | 496 |
|
|
2023
Q1 | $192K | Buy |
38,835
+9,856
| +34% | +$48.7K | 0.01% | 475 |
|
|
2022
Q4 | $182K | Buy |
28,979
+10,750
| +59% | +$67.6K | 0.01% | 458 |
|
|
2022
Q3 | $197K | Hold |
18,229
| – | – | 0.01% | 457 |
|
|
2022
Q2 | $208K | Hold |
18,229
| – | – | 0.01% | 453 |
|
|
2022
Q1 | $166K | Hold |
18,229
| – | – | 0.01% | 432 |
|
|
2021
Q4 | $272K | Hold |
18,229
| – | – | 0.01% | 415 |
|
|
2021
Q3 | $468K | Hold |
18,229
| – | – | 0.02% | 351 |
|
|
2021
Q2 | $475K | Hold |
18,229
| – | – | 0.02% | 359 |
|
|
2021
Q1 | $643K | Hold |
18,229
| – | – | 0.02% | 319 |
|
|
2020
Q4 | $460K | Hold |
18,229
| – | – | 0.02% | 440 |
|
|
2020
Q3 | $687K | Sell |
18,229
-2,657
| -13% | -$100K | 0.03% | 367 |
|
|
2020
Q2 | $894K | Sell |
20,886
-1,720
| -8% | -$73.6K | 0.04% | 310 |
|
|
2020
Q1 | $439K | Buy |
22,606
+141
| +0.6% | +$2.74K | 0.02% | 414 |
|
|
2019
Q4 | $584K | Hold |
22,465
| – | – | 0.02% | 414 |
|
|
2019
Q3 | $612K | Hold |
22,465
| – | – | 0.02% | 436 |
|
|
2019
Q2 | $603K | Buy |
+22,465
| New | +$603K | 0.02% | 476 |
|